Related Experiment Video
Updated: Jul 19, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Pathology associated with sporadic Parkinson's disease--where does it end?
1Institute for Clinical Neuroanatomy, J.W. Goethe University, Frankfurt/Main, Germany. Braak@em.uni-frankfurt.de
Journal of Neural Transmission. Supplementum
|October 5, 2006
Summary
Parkinson's disease pathology typically follows a predictable 6-stage progression. However, some cases show divergent Lewy body pathology, particularly with Alzheimer's disease co-occurrence.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Brain Aging
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting multiple nervous system levels.
- A 6-stage staging system for PD-related Lewy body pathology exists, detailing progression through specific brain regions.
- This system proposes a topographically predictable sequence of pathology spread.
Purpose of the Study:
- To investigate the topographical progression of Lewy body pathology in Parkinson's disease.
- To identify deviations from the established 6-stage staging procedure.
- To analyze the characteristics of cases with divergent pathological patterns.
Main Methods:
- Analysis of 301 autopsy cases with Parkinson's disease-related pathology.
- Examination of 163 age-matched control cases.
- Staging of Lewy neurites and Lewy bodies in brain tissue according to established criteria.
Main Results:
- The established 6-stage staging procedure was applied to 301 autopsy cases.
- A total of 19 cases (6.3%) exhibited a divergent pathological distribution pattern.
- These divergent cases predominantly involved olfactory structures and the amygdala, with minimal brainstem pathology, and often co-occurred with advanced Alzheimer's disease.
Conclusions:
- While the 6-stage staging system for Parkinson's disease pathology is generally applicable, atypical patterns exist.
- Divergent Lewy body pathology, particularly in the presence of Alzheimer's disease, warrants further investigation.
- Understanding these variations is crucial for refining diagnostic and prognostic approaches in neurodegenerative disorders.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.